Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 42 | 2025 | 990 | 12.830 |
Why?
|
| Apolipoprotein E4 | 17 | 2025 | 251 | 6.640 |
Why?
|
| Alzheimer Disease | 23 | 2025 | 2036 | 5.020 |
Why?
|
| Aged | 82 | 2025 | 8732 | 3.600 |
Why?
|
| Cognition | 30 | 2024 | 1250 | 3.400 |
Why?
|
| tau Proteins | 6 | 2025 | 225 | 2.870 |
Why?
|
| Chicago | 29 | 2025 | 898 | 2.830 |
Why?
|
| Female | 88 | 2025 | 14734 | 2.790 |
Why?
|
| Neurofilament Proteins | 4 | 2025 | 17 | 2.740 |
Why?
|
| Male | 78 | 2025 | 14277 | 2.670 |
Why?
|
| Cognition Disorders | 14 | 2018 | 957 | 2.610 |
Why?
|
| Humans | 105 | 2025 | 25967 | 2.510 |
Why?
|
| Stroke | 6 | 2023 | 259 | 2.470 |
Why?
|
| Aged, 80 and over | 41 | 2025 | 4641 | 2.410 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 123 | 2.340 |
Why?
|
| Longitudinal Studies | 28 | 2025 | 1333 | 2.320 |
Why?
|
| Aging | 14 | 2025 | 1483 | 2.180 |
Why?
|
| Cohort Studies | 25 | 2025 | 1806 | 2.080 |
Why?
|
| Biomarkers | 11 | 2025 | 544 | 2.030 |
Why?
|
| Risk Factors | 25 | 2025 | 2237 | 1.920 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2025 | 43 | 1.810 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 235 | 1.790 |
Why?
|
| Alleles | 9 | 2024 | 204 | 1.770 |
Why?
|
| Blood Pressure | 3 | 2024 | 184 | 1.550 |
Why?
|
| Exercise | 9 | 2023 | 434 | 1.520 |
Why?
|
| White Matter | 3 | 2022 | 131 | 1.490 |
Why?
|
| Activities of Daily Living | 9 | 2018 | 575 | 1.490 |
Why?
|
| Prospective Studies | 15 | 2025 | 1701 | 1.390 |
Why?
|
| Population Surveillance | 3 | 2021 | 112 | 1.370 |
Why?
|
| Dementia | 9 | 2024 | 524 | 1.290 |
Why?
|
| Vitamin E | 2 | 2023 | 43 | 1.220 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 19 | 1.200 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 307 | 1.170 |
Why?
|
| Genotype | 7 | 2024 | 339 | 1.160 |
Why?
|
| Incidence | 12 | 2025 | 729 | 1.140 |
Why?
|
| Memory Disorders | 3 | 2024 | 154 | 1.090 |
Why?
|
| Disease Progression | 11 | 2019 | 655 | 1.090 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2024 | 30 | 1.070 |
Why?
|
| Loneliness | 2 | 2025 | 54 | 1.070 |
Why?
|
| Diet, Mediterranean | 3 | 2024 | 82 | 1.050 |
Why?
|
| Mortality | 4 | 2021 | 87 | 1.010 |
Why?
|
| Lipids | 1 | 2025 | 48 | 0.920 |
Why?
|
| Social Isolation | 1 | 2025 | 26 | 0.910 |
Why?
|
| United States | 12 | 2024 | 1989 | 0.890 |
Why?
|
| Disability Evaluation | 4 | 2014 | 255 | 0.880 |
Why?
|
| Dietary Fats | 1 | 2024 | 39 | 0.860 |
Why?
|
| Whole Grains | 1 | 2023 | 4 | 0.860 |
Why?
|
| Neuropathology | 3 | 2021 | 79 | 0.800 |
Why?
|
| Depression | 4 | 2014 | 412 | 0.800 |
Why?
|
| Vitamin D | 1 | 2022 | 31 | 0.760 |
Why?
|
| Healthy Lifestyle | 5 | 2024 | 41 | 0.750 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 46 | 0.740 |
Why?
|
| Independent Living | 5 | 2025 | 283 | 0.720 |
Why?
|
| Membrane Proteins | 1 | 2021 | 169 | 0.670 |
Why?
|
| Geriatric Assessment | 5 | 2021 | 201 | 0.650 |
Why?
|
| Follow-Up Studies | 11 | 2024 | 1757 | 0.610 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 1150 | 0.590 |
Why?
|
| Time Factors | 10 | 2021 | 1391 | 0.580 |
Why?
|
| Diet | 4 | 2023 | 197 | 0.580 |
Why?
|
| Art | 1 | 2016 | 1 | 0.530 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 366 | 0.520 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 53 | 0.520 |
Why?
|
| Music | 1 | 2016 | 22 | 0.520 |
Why?
|
| Diabetes Complications | 1 | 2016 | 55 | 0.510 |
Why?
|
| Models, Statistical | 2 | 2021 | 126 | 0.500 |
Why?
|
| Life Style | 5 | 2022 | 177 | 0.490 |
Why?
|
| Prevalence | 3 | 2023 | 433 | 0.480 |
Why?
|
| Obesity | 6 | 2014 | 297 | 0.480 |
Why?
|
| Mobility Limitation | 2 | 2015 | 92 | 0.460 |
Why?
|
| Cognitive Aging | 4 | 2021 | 77 | 0.460 |
Why?
|
| Body Mass Index | 6 | 2018 | 449 | 0.450 |
Why?
|
| Depressive Disorder | 1 | 2015 | 172 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 160 | 0.440 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 17 | 0.440 |
Why?
|
| Dopamine Agents | 1 | 2014 | 11 | 0.430 |
Why?
|
| Memantine | 1 | 2014 | 9 | 0.430 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 263 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 268 | 0.430 |
Why?
|
| Antioxidants | 1 | 2014 | 60 | 0.420 |
Why?
|
| Motor Activity | 2 | 2015 | 317 | 0.420 |
Why?
|
| Health Status Disparities | 1 | 2013 | 73 | 0.390 |
Why?
|
| Memory, Episodic | 3 | 2018 | 110 | 0.390 |
Why?
|
| Diagnosis | 1 | 2011 | 23 | 0.370 |
Why?
|
| Area Under Curve | 1 | 2011 | 63 | 0.370 |
Why?
|
| Medical Informatics | 1 | 2011 | 10 | 0.370 |
Why?
|
| Linear Models | 3 | 2016 | 240 | 0.350 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.340 |
Why?
|
| Disabled Persons | 1 | 2012 | 107 | 0.340 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 466 | 0.340 |
Why?
|
| Age of Onset | 3 | 2014 | 89 | 0.300 |
Why?
|
| Middle Aged | 21 | 2019 | 8772 | 0.300 |
Why?
|
| Genetic Loci | 3 | 2018 | 51 | 0.290 |
Why?
|
| Postmenopause | 7 | 2006 | 57 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 1059 | 0.260 |
Why?
|
| Hypertension | 2 | 2024 | 181 | 0.250 |
Why?
|
| Triglycerides | 2 | 2025 | 56 | 0.250 |
Why?
|
| Neuroticism | 2 | 2023 | 32 | 0.240 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 36 | 0.230 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.230 |
Why?
|
| Cholesterol | 1 | 2025 | 59 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.230 |
Why?
|
| Air Pollution | 1 | 2024 | 14 | 0.230 |
Why?
|
| Environmental Exposure | 1 | 2024 | 18 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 17 | 0.230 |
Why?
|
| Survivors | 3 | 2022 | 68 | 0.230 |
Why?
|
| Heterozygote | 1 | 2025 | 98 | 0.220 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 309 | 0.220 |
Why?
|
| Adult | 11 | 2023 | 7662 | 0.210 |
Why?
|
| Florida | 1 | 2023 | 17 | 0.210 |
Why?
|
| Sex Factors | 2 | 2022 | 454 | 0.210 |
Why?
|
| Risk Assessment | 2 | 2024 | 603 | 0.210 |
Why?
|
| Tocopherols | 1 | 2023 | 8 | 0.200 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 13 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 7 | 0.200 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 6 | 0.200 |
Why?
|
| Regression Analysis | 4 | 2011 | 251 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 16 | 0.200 |
Why?
|
| Brain Infarction | 1 | 2023 | 76 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2022 | 58 | 0.190 |
Why?
|
| Age Factors | 2 | 2022 | 757 | 0.190 |
Why?
|
| Life Expectancy | 1 | 2022 | 26 | 0.190 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 39 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2014 | 227 | 0.180 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 3 | 0.180 |
Why?
|
| Brain | 4 | 2024 | 1569 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 36 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 49 | 0.170 |
Why?
|
| Noise | 1 | 2020 | 24 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2020 | 57 | 0.170 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 89 | 0.160 |
Why?
|
| Neuroimaging | 1 | 2020 | 120 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 151 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 205 | 0.150 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 213 | 0.150 |
Why?
|
| Confidence Intervals | 2 | 2017 | 92 | 0.150 |
Why?
|
| Phototherapy | 1 | 2019 | 27 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Social Networking | 1 | 2018 | 9 | 0.150 |
Why?
|
| Hippocampus | 1 | 2020 | 266 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2018 | 14 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2016 | 124 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 12 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 26 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2017 | 268 | 0.140 |
Why?
|
| Nursing Homes | 1 | 2018 | 41 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 294 | 0.140 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 1107 | 0.140 |
Why?
|
| Social Environment | 1 | 2018 | 77 | 0.140 |
Why?
|
| Parkinson Disease | 2 | 2022 | 640 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 141 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 9 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2019 | 128 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 83 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 25 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 18 | 0.130 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mucormycosis | 1 | 2017 | 8 | 0.130 |
Why?
|
| Frozen Sections | 1 | 2017 | 14 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2017 | 13 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.130 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproduction | 1 | 2016 | 10 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 267 | 0.130 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 113 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 44 | 0.130 |
Why?
|
| Warfare | 1 | 2016 | 12 | 0.130 |
Why?
|
| Terrorism | 1 | 2016 | 9 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2014 | 40 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 37 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2015 | 207 | 0.120 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 6 | 0.120 |
Why?
|
| Overweight | 2 | 2014 | 69 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 217 | 0.120 |
Why?
|
| Insulin | 2 | 2014 | 84 | 0.120 |
Why?
|
| Health Status | 2 | 2014 | 214 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.120 |
Why?
|
| Carbohydrates | 1 | 2015 | 5 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 10 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 102 | 0.120 |
Why?
|
| Urinalysis | 1 | 2015 | 8 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 32 | 0.120 |
Why?
|
| Rhinitis | 1 | 2017 | 136 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2005 | 76 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 169 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2015 | 58 | 0.110 |
Why?
|
| Sinusitis | 1 | 2017 | 153 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 71 | 0.110 |
Why?
|
| Hospitalization | 2 | 2014 | 301 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cats | 1 | 2014 | 28 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 12 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 67 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 116 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 58 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 155 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 207 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 221 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 332 | 0.100 |
Why?
|
| Mindfulness | 1 | 2014 | 46 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 296 | 0.100 |
Why?
|
| Emergency Medicine | 1 | 2015 | 93 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 337 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 121 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 149 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2013 | 73 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 190 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 61 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 40 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2011 | 40 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 110 | 0.090 |
Why?
|
| ROC Curve | 1 | 2011 | 141 | 0.090 |
Why?
|
| Gait | 1 | 2015 | 408 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 402 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 35 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 92 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2010 | 46 | 0.080 |
Why?
|
| Testosterone | 3 | 2004 | 28 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 89 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 605 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 193 | 0.080 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 362 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 473 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 345 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 5 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 1941 | 0.060 |
Why?
|
| Animals | 1 | 2014 | 3503 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 97 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 390 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 290 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 17 | 0.060 |
Why?
|
| Feces | 2 | 2017 | 80 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 38 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 97 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Copper | 1 | 2024 | 16 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 46 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 12 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 95 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 39 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 393 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 5 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 7 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 56 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 179 | 0.050 |
Why?
|
| Estrogens | 1 | 2004 | 26 | 0.050 |
Why?
|
| Parents | 1 | 2005 | 110 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 10 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 7 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 8 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 851 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 48 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 91 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 15 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 26 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 391 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.040 |
Why?
|
| Atrophy | 1 | 2021 | 83 | 0.040 |
Why?
|
| Tremor | 1 | 2022 | 101 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 334 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 72 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 180 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 285 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1217 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 38 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 50 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 19 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 9 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 22 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 12 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 56 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 42 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 18 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 102 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 2099 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 143 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 16 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 87 | 0.030 |
Why?
|
| Educational Status | 1 | 2018 | 282 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 26 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2019 | 133 | 0.030 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.030 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.030 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 41 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 13 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 10 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 42 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 18 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 4 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 32 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 11 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 15 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 288 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 175 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 46 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 571 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 222 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 327 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 23 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 173 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 3 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 5 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 125 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 43 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 6 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 15 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 37 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 37 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 216 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 30 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3358 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 96 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 66 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 178 | 0.030 |
Why?
|
| China | 1 | 2014 | 48 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 6 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 132 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 23 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 8 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 58 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 113 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 38 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 16 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 53 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 174 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 37 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 149 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 616 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 106 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 633 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 137 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 110 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 102 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 708 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 248 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 307 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 75 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 202 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 297 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 15 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 210 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 193 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 868 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 9 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 24 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 44 | 0.010 |
Why?
|
| Leptin | 1 | 2005 | 19 | 0.010 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.010 |
Why?
|
| Body Size | 1 | 2004 | 9 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 65 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 50 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 68 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 19 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 26 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 77 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 54 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 64 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 5 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 30 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 83 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 360 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 648 | 0.010 |
Why?
|